These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26775630)

  • 1. How Safe Is Moderate Alcohol Consumption in Overweight and Obese Individuals?
    Sookoian S; Pirola CJ
    Gastroenterology; 2016 Jun; 150(8):1698-1703.e2. PubMed ID: 26775630
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction Between Alcohol Use and Metabolic Risk Factors for Liver Disease: A Critical Review of Epidemiological Studies.
    Åberg F; Färkkilä M; Männistö V
    Alcohol Clin Exp Res; 2020 Feb; 44(2):384-403. PubMed ID: 31854001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Implications of Concomitant Alcohol Use, Obesity, and Viral Hepatitis.
    Serfaty L
    Gastroenterology; 2016 Jun; 150(8):1718-22. PubMed ID: 26873400
    [No Abstract]   [Full Text] [Related]  

  • 4. Drinking and Obesity: Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Interactions.
    Åberg F; Färkkilä M
    Semin Liver Dis; 2020 May; 40(2):154-162. PubMed ID: 32069503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatty liver disease and lifestyle in youngsters: diet, food intake frequency, exercise, sleep shortage and fashion.
    Trovato FM; Martines GF; Brischetto D; Catalano D; Musumeci G; Trovato GM
    Liver Int; 2016 Mar; 36(3):427-33. PubMed ID: 26346413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mendelian randomisation suggests no beneficial effect of moderate alcohol consumption on the severity of nonalcoholic fatty liver disease.
    Sookoian S; Flichman D; Castaño GO; Pirola CJ
    Aliment Pharmacol Ther; 2016 Dec; 44(11-12):1224-1234. PubMed ID: 27778410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-alcoholic fatty liver disease (NAFLD)].
    Rau M; Weiss J; Geier A
    Dtsch Med Wochenschr; 2015 Jul; 140(14):1051-5. PubMed ID: 26182253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk.
    Du T; Yu X; Yuan G; Zhang J; Sun X
    Cardiovasc Diabetol; 2015 Oct; 14():144. PubMed ID: 26511621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alcohol and Liver Transplantation.
    Testino G; Leone S
    Alcohol Alcohol; 2017 Jan; 52(1):126. PubMed ID: 27600939
    [No Abstract]   [Full Text] [Related]  

  • 12. Biphasic effect of alcohol intake on the development of fatty liver disease.
    Takahashi H; Ono M; Hyogo H; Tsuji C; Kitajima Y; Ono N; Eguchi T; Fujimoto K; Chayama K; Saibara T; Anzai K; Eguchi Y
    J Gastroenterol; 2015 Nov; 50(11):1114-23. PubMed ID: 25733100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease.
    Sinn DH; Gwak GY; Cho J; Son HJ; Paik YH; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC
    Atherosclerosis; 2014 Jun; 234(2):270-5. PubMed ID: 24704629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial: alcohol and obesity - the double peril.
    Lockman KA
    Aliment Pharmacol Ther; 2015 Apr; 41(7):694. PubMed ID: 25736142
    [No Abstract]   [Full Text] [Related]  

  • 15. The value of different insulin resistance indices in assessment of non-alcoholic fatty liver disease in overweight/obese children.
    El-Karaksy HM; El-Raziky MS; Fouad HM; Anwar GM; El-Mougy FM; El-Koofy NM; El-Hennawy AM
    Diabetes Metab Syndr; 2015; 9(2):114-9. PubMed ID: 25470627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty liver index vs waist circumference for predicting non-alcoholic fatty liver disease.
    Motamed N; Sohrabi M; Ajdarkosh H; Hemmasi G; Maadi M; Sayeedian FS; Pirzad R; Abedi K; Aghapour S; Fallahnezhad M; Zamani F
    World J Gastroenterol; 2016 Mar; 22(10):3023-30. PubMed ID: 26973398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of and risk factors for non-alcoholic fatty liver disease in a Chinese population: An 8-year follow-up study.
    Lu ZY; Shao Z; Li YL; Wulasihan M; Chen XH
    World J Gastroenterol; 2016 Apr; 22(13):3663-9. PubMed ID: 27053858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease.
    Lee YC; Wu JS; Yang YC; Chang CS; Lu FH; Chang CJ
    Scand J Gastroenterol; 2014 Aug; 49(8):1001-6. PubMed ID: 24989169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward More Accurate Nomenclature for Fatty Liver Diseases.
    Eslam M; Sanyal AJ; George J
    Gastroenterology; 2019 Sep; 157(3):590-593. PubMed ID: 31158374
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of weight gain since age 20 with non-alcoholic fatty liver disease in normal weight individuals.
    Kimura T; Deshpande GA; Urayama KY; Masuda K; Fukui T; Matsuyama Y
    J Gastroenterol Hepatol; 2015 May; 30(5):909-17. PubMed ID: 25469977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.